Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01948505 · ClinicalTrials.gov registry record · Phase 4

Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit

A Phase 4 study, sponsored by University of Utah.

Completed
Registry status
Phase 4
Development phase
210
Enrollment target

NCT01948505 is a Phase 4 study that has completed, run by University of Utah. The registered enrollment target is 210 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01948505, a Phase 4 study, has completed, sponsored by University of Utah.

COMPLETED
Registry status
Phase 4
Development phase
210 participants
Enrollment target

Study Summary

To assess the efficacy of an intravenous nonnarcotic pain medication on controlling patient pain. To assess the effect of an intravenous nonnarcotic pain medication on patient sedation levels in neurocritically ill patients. To assess the effect of an intravenous nonnarcotic pain medication on common side effects seen in patients taking other intravenous narcotic pain medication in the neurocritical care unit.

Interventions

  • DRUG Intravenous acetaminophen
  • DRUG Placebo for IV acetaminophen

Trial Details

FieldValue
Enrollment Target 210 participants
Start Date 2013-08
Est. Completion 2016-11
Phase Phase 4

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT01948505

The ClinicalTrials.gov registry entry for NCT01948505 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Intravenous acetaminophen is the first listed.

NCT01948505 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01948505 about?

NCT01948505 is a clinical study titled "Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit". To assess the efficacy of an intravenous nonnarcotic pain medication on controlling patient pain. To assess the effect of an intravenous nonnarcotic pain medication on patient sedation levels in neurocritically ill patients. To assess the effect of an intravenous nonnarcotic pain medication on com...

What is the current status of trial NCT01948505?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 210 participants. The study started on 2013-08. Estimated completion is 2016-11.

What interventions are being tested in trial NCT01948505?

The interventions under investigation include: Intravenous acetaminophen (DRUG), Placebo for IV acetaminophen (DRUG).

Who is sponsoring clinical trial NCT01948505?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.